Dov-Val-Dil-OH TFA - CAS 133120-90-8 Catalog number: BADC-01576

Dov-Val-Dil-OH TFA, also known by its full chemical name N-(2,2-dimethyl-1,3-dioxolane-4-yl)valine trifluoroacetate, is a significant compound in the realm of pharmaceutical research and development. It belongs to a class of compounds known as peptide derivatives, which are synthesized by the modification of naturally occurring peptides. Peptides themselves are short chains of amino acid monomers linked by peptide (amide) bonds. Given their mimicry of natural biological molecules, peptide derivatives like Dov-Val-Dil-OH TFA are frequently utilized in medicinal chemistry for drug development and understanding biological processes.

Peptide derivatives, including Dov-Val-Dil-OH TFA, have been increasingly utilized in the field of drug discovery due to their high specificity and potency. They can interact with a vast array of biological targets, providing a unique tool for designing drugs that might have fewer off-target effects compared to small molecules. The trifluoroacetate in Dov-Val-Dil-OH TFA serves as a counterion which can improve the compound’s solubility and stability, crucial characteristics for its storage and handling in laboratory settings. This modification may also influence how the compound interacts at the molecular level within biological systems, catering to enhanced interaction with target proteins or receptors.

The role of Dov-Val-Dil-OH TFA in drug discovery is particularly pronounced in the exploration of new therapeutic targets. In pharmaceutical research, the priority is often to identify compounds that can specifically interact with biological targets associated with disease. Peptide derivatives like Dov-Val-Dil-OH TFA can be engineered to bind selectively to such targets thanks to their tailored chemical structure, thus offering powerful scaffolds for drug design. Moreover, these compounds often exhibit minimized immunogenicity due to their peptide nature, reducing potential adverse immune responses which is a significant concern in drug development.

Another crucial aspect of Dov-Val-Dil-OH TFA’s application in drug discovery is its role in the lead optimization phase. After initial potential therapeutic compounds are identified, modifications are necessary to enhance certain characteristics such as efficacy, potency, safety, and pharmacokinetic properties. Through systematic structural variations, peptide derivatives like Dov-Val-Dil-OH TFA allow researchers to fine-tune these properties, optimizing the compound’s therapeutic potential and its eventual clinical success. The trifluoroacetate salt form further assists in improving pharmacokinetics by altering the compound’s absorption and distribution in the body.

Additionally, Dov-Val-Dil-OH TFA and similar compounds are valuable in the study of enzyme-substrate interactions and in the design of enzyme inhibitors. Enzymes play critical roles in numerous metabolic pathways, and their dysregulation is a common cause of diseases. By designing inhibitors based on peptide derivatives, researchers can effectively suppress pathogenic enzymatic activity, paving the way for the development of therapeutic agents to treat conditions ranging from cancer to infectious diseases. Specifically, the dioxolane moiety in Dov-Val-Dil-OH TFA derivatives might confer a competitive edge in inhibiting enzymes by mimicking natural substrates more closely, therefore achieving higher binding affinity and specificity.